Literature DB >> 11520206

QSAR study on the contribution of log P and E(s) to the in vitro antiprotozoal activity of glutathione derivatives.

S Daunes1, C D'Silva, H Kendrick, V Yardley, S L Croft.   

Abstract

A series of N-S-blocked glutathione monoester and diester derivatives based on N-benzyloxycarbonyl-S-(2,4-dinitrophenyl)glutathione were evaluated for activity against the pathogenic parasites Trypanosoma brucei brucei, Trypanosoma cruzi, and Leishmania donovani in vitro.Only monoesters 7-9 with a log P value of >2.7 were active inhibitors of T.b. brucei bloodstream form trypomastigotes. Diester compounds 10-15 and 17-27 in most cases were better inhibitors of T.b. brucei than monoester compounds, and some displayed high activity against T. cruzi 14 and L. donovani 17, 19, 29. Compounds 14, 24, and 25 were the most active compounds identified against T.b. brucei having ED(50) values of <0.4 microM. Analysis of the inhibition data (ED(50)) vs calculated log P and E(s) values provided evidence to support membrane penetration and steric factors as the key component in the activity of these compounds. The optimum values for log P and E(s) determined were 5.8 and -0.70, respectively. A QSAR equation relating log(1/ED(50)) vs log P and E(s) was determined and interpreted within the proposed mechanism of activity for these compounds.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11520206     DOI: 10.1021/jm000502n

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Structure-property correlation and estimation of the antiparasitic activity of glutathione derivatives.

Authors:  I B Golovanov; S M Zhenodarova; G R Ivanitskii; M I Khabarova
Journal:  Dokl Biochem Biophys       Date:  2002 Nov-Dec       Impact factor: 0.788

2.  Glutathione derivatives active against Trypanosoma brucei rhodesiense and T. brucei brucei in vitro.

Authors:  Sylvie Daunes; Claudius D'Silva
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

3.  Application of linear discriminant analysis in the virtual screening of antichagasic drugs through trypanothione reductase inhibition.

Authors:  Julián J Prieto; Alan Talevi; Luis E Bruno-Blanch
Journal:  Mol Divers       Date:  2006-09-21       Impact factor: 2.943

4.  Ensemble learning application to discover new trypanothione synthetase inhibitors.

Authors:  Juan I Alice; Carolina L Bellera; Diego Benítez; Marcelo A Comini; Pablo R Duchowicz; Alan Talevi
Journal:  Mol Divers       Date:  2021-07-15       Impact factor: 2.943

5.  Neglected disease - african sleeping sickness: recent synthetic and modeling advances.

Authors:  Sarvesh K Paliwal; Ankita Narayan Verma; Shailendra Paliwal
Journal:  Sci Pharm       Date:  2011-05-10

6.  Inhibition of poly(ADP-ribose) polymerase interferes with Trypanosoma cruzi infection and proliferation of the parasite.

Authors:  Salomé C Vilchez Larrea; Teemu Haikarainen; Mohit Narwal; Mariana Schlesinger; Harikanth Venkannagari; Mirtha M Flawiá; Silvia H Fernández Villamil; Lari Lehtiö
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

7.  Stilbene glycosides are natural product inhibitors of FGF-2-induced angiogenesis.

Authors:  Sajjad Hussain; Mark Slevin; Nessar Ahmed; David West; Muhammad Iqbal Choudhary; Humera Naz; John Gaffney
Journal:  BMC Cell Biol       Date:  2009-04-23       Impact factor: 4.241

8.  Identification of Novel Chemical Scaffolds Inhibiting Trypanothione Synthetase from Pathogenic Trypanosomatids.

Authors:  Diego Benítez; Andrea Medeiros; Lucía Fiestas; Esteban A Panozzo-Zenere; Franziska Maiwald; Kyriakos C Prousis; Marina Roussaki; Theodora Calogeropoulou; Anastasia Detsi; Timo Jaeger; Jonas Šarlauskas; Lucíja Peterlin Mašič; Conrad Kunick; Guillermo R Labadie; Leopold Flohé; Marcelo A Comini
Journal:  PLoS Negl Trop Dis       Date:  2016-04-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.